CURRENT ISSUE Current Issue Cover
VOL 9 • NO 5 JUL/AUG 2018


Epidermal Growth Factor Receptor Inhibitor Skin Rash Prophylaxis in a Community Oncology Setting

Micah S. Pepper,(1) PharmD, BCPS, and Megan May,(2) PharmD, BCOP

Hypercalcemia of Malignancy

Kaitlin L. Feldenzer,(1) DNP, RN, OCN®, and Jessica Sarno,(2) MSN, ACNP-BC, AOCNP®

 
Section Seperator

TODAY'S NEWS

FDA Approves Pembrolizumab in Combinatio...

Today, the U.S. Food and Drug Administration (FDA)...

FDA Updates Prescribing Information for ...

On August 16, 2018, the U.S. Food and Drug Adminis...

Impact of Doctor-Patient Communication o...

A new study from the American Cancer Society has f...

Cetuximab With Radiotherapy Found to Be ...

An interim analysis of data from a randomized clin...

Addition of Vincristine and Irinotecan t...

In a phase III Children’s Oncology Group stu...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Enhanced Recovery After Surgery

Enhanced recovery after surgery (ERAS) is a multimodal perioperative care pathway...

NP's Experience: Lung Cancer Screening Program

Lung cancer screening with low-dose computed tomography of the chest is now a service covered by...

Subcutaneous Rituximab in Lymphomas, CLL

Rituximab and hyaluronidase human is a new subcutaneous formulation of rituximab...

Tisagenlecleucel: The First CAR on the Highway

Tisagenlecleucel is a first-in-class chimeric antigen receptor (CAR) T-cell therapy...

Presenting With Confidence

Often, advanced practitioners must give clinical presentations. Public speaking, which is a major fear...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Bevacizumab and Temozolomide in First Re...

In a phase II trial reported in The Lancet Oncolog...

FDA Approves Nivolumab for Certain Patie...

Today, nivolumab (Opdivo) received approval from t...

BRCA Testing in Medically Underserved Wo...

Only 8% of disabled or older women in the Southern...

FDA Accepts Biologics License Applicatio...

The U.S. Food and Drug Administration (FDA) has ac...

Functional and Social Independence in Su...

In a report from the St. Jude Lifetime Cohort Stud...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.